BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 7486808)

  • 1. Mivacurium sensitivity in a patient heterozygous for the atypical and silent genes for plasma cholinesterase.
    Robertson WS; Shaikh J; Purdie DW
    Ann Clin Biochem; 1995 Jul; 32 ( Pt 4)():431-3. PubMed ID: 7486808
    [No Abstract]   [Full Text] [Related]  

  • 2. Mivacurium-induced neuromuscular blockade in patients with atypical plasma cholinesterase.
    Ostergaard D; Jensen FS; Jensen E; Skovgaard LT; Viby-Mogensen J
    Acta Anaesthesiol Scand; 1993 Apr; 37(3):314-8. PubMed ID: 8390770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolonged paralysis after a test dose of mivacurium in a patient with atypical serum cholinesterase.
    Vanlinthout LE; Bartels CF; Lockridge O; Callens K; Booij LH
    Anesth Analg; 1998 Nov; 87(5):1199-202. PubMed ID: 9806709
    [No Abstract]   [Full Text] [Related]  

  • 4. Dose-response relationship for mivacurium in patients with phenotypically abnormal plasma cholinesterase activity.
    Ostergaard D; Jensen FS; Skovgaard LT; Viby-Mogensen J
    Acta Anaesthesiol Scand; 1995 Nov; 39(8):1016-8. PubMed ID: 8607300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics and pharmacodynamics of mivacurium in patients phenotypically heterozygous for the usual and atypical plasma cholinesterase variants (UA).
    Østergaard D; Viby-Mogensen J; Rasmussen SN; Gätke MR; Pedersen NA; Skovgaard LT
    Acta Anaesthesiol Scand; 2003 Nov; 47(10):1219-25. PubMed ID: 14616318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Markedly prolonged paralysis after mivacurium in a patient apparently heterozygous for the atypical and usual pseudocholinesterase alleles by conventional biochemical testing.
    Rosenberg MK; Lebenbom-Mansour M
    Anesth Analg; 1997 Feb; 84(2):457-60. PubMed ID: 9024049
    [No Abstract]   [Full Text] [Related]  

  • 7. [Prolonged neuromuscular blockade caused by mivacurium in a pediatric patient].
    Fernández-Rosado B; Vázquez-Fidalgo A; Pensado-Castiñeiras A; Figueira-Moure A; Rama-Maceiras P; Pose-Cambeiro P
    Rev Esp Anestesiol Reanim; 1999 Feb; 46(2):92. PubMed ID: 10100446
    [No Abstract]   [Full Text] [Related]  

  • 8. Reversal of intense mivacurium block with human plasma cholinesterase in patients with atypical plasma cholinesterase.
    Ostergaard D; Jensen FS; Viby-Mogensen J
    Anesthesiology; 1995 May; 82(5):1295-8. PubMed ID: 7741307
    [No Abstract]   [Full Text] [Related]  

  • 9. Mivacurium apnoea.
    Lightman DJ
    Anaesthesia; 1994 Sep; 49(9):835. PubMed ID: 7978163
    [No Abstract]   [Full Text] [Related]  

  • 10. [Prolonged curarization after administration of mivacurium].
    Soulard D; Blanloeil Y; de Laroche O; Burnat P; Magerand P
    Cah Anesthesiol; 1996; 44(5):429-31. PubMed ID: 9183424
    [No Abstract]   [Full Text] [Related]  

  • 11. Prolonged neuromuscular block after mivacurium.
    Petersen RS; Bailey PL; Kalameghan R; Ashwood ER
    Anesth Analg; 1993 Jan; 76(1):194-6. PubMed ID: 8418724
    [No Abstract]   [Full Text] [Related]  

  • 12. Prolonged neuromuscular block with mivacurium in a patient with cholinesterase deficiency.
    Wong TK; Chen C; Liou SC; Lee YH; Huang CS
    J Formos Med Assoc; 2000 Aug; 99(8):656-8. PubMed ID: 10969512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Plasma cholinesterase variations as a result of prolonged neuromuscular blockade. Review and problems encountered in two cases of prolonged neuromuscular blockade after muscle relaxation with succinylcholine as compared to mivacurium].
    Lang C; Lukasewitz P; Wulf H; Geldner G
    Anaesthesist; 2002 Feb; 51(2):134-41. PubMed ID: 11963306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patient information sheet for plasma cholinesterase deficiency.
    Dillon D; Lee P
    Anaesthesia; 2013 Oct; 68(10):1085. PubMed ID: 24047308
    [No Abstract]   [Full Text] [Related]  

  • 15. Reversal of mivacurium apnoea with neostigmine.
    Bell M
    Anaesthesia; 1994 Apr; 49(4):350. PubMed ID: 8179151
    [No Abstract]   [Full Text] [Related]  

  • 16. Test dose for prediction of mivacurium sensitivity in the patient with atypical plasma cholinesterase.
    Baraka A
    Anesthesiology; 1995 Dec; 83(6):1371-2. PubMed ID: 8533937
    [No Abstract]   [Full Text] [Related]  

  • 17. Increased plasma cholinesterase activity and mivacurium resistance: report of a family.
    Naguib M; Gomaa M; Samarkandi AH; Bevan DR; Akkielah AK; Watson C; Billecke S; La Du BN
    Anesth Analg; 1999 Dec; 89(6):1579-82. PubMed ID: 10589654
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical importance of plasma cholinesterase for the anaesthetist.
    Pedersen NA; Jensen FS
    Ann Acad Med Singap; 1994 Nov; 23(6 Suppl):120-4. PubMed ID: 7710221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of cholinesterase activity on pharmacodynamics of mivacurium preceded by pancuronium in elderly and young adults.
    Osman ES; Khafagy HF; Radwan KG; Desouky AM
    J Egypt Soc Parasitol; 2007 Apr; 37(1):243-55. PubMed ID: 17580581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics and pharmacodynamics of mivacurium in patients phenotypically homozygous for the atypical plasma cholinesterase variant: effect of injection of human cholinesterase.
    Østergaard D; Viby-Mogensen J; Rasmussen SN; Gätke MR; Varin F
    Anesthesiology; 2005 Jun; 102(6):1124-32. PubMed ID: 15915024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.